Drugs / SCB-420
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04919096 | Apr → Sep 2022 | wet macular degeneration | Clover Biopharmaceuticals AUS Pty | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCB-420 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04919096 ↗ |